Blood pressure medication recalled over possibly containing cancer-causing 'impurity'

A Lupin Pharmaceuticals Inc. blood pressure medication is being recalled by the U.S. Food and Drug Administration (FDA) for potentially containing a "probable human carcinogen."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.